What We Know of the Prognostic Value of Lymphopenia in SARS-CoV-2 Infection

نویسندگان
Salari, Sina ID 1
Abolghasemi, Hassan ID 2
Pourbagheri-Sigaroodi, Atieh ID 3
Bashash, Davood ID 4
Olfatifar, Meysam ID 5

1 Department of Medical Oncology, Hematology and Bone Marrow Transplantation, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Pediatric Congenital Hematologic Disorders Research Center, Mofid Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

3 Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4 Department of Hematology and Blood Banking, School of Allied Medical Sciences Shahid Beheshti University of Medical Sciences, Tehran, Iran

5 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

doi
چکیده

Background: Although by comparing the number of deaths to the total number of cases one may conclude that most of the infected cases are recovering, taking a look at the increasing statistics of deaths shows that SARS-CoV-2 continues to take its toll. Since lymphocytes are the main immune cells battling with ...

کلیدواژه‌ها
SARS-CoV-2, COVID-19, Prognosis, Lymphocyte, Lymphopenia, Meta-analysis